← Back to Search

Behavioural Intervention

SurePace Powered Walker User for Cerebral Palsy

Waitlist Available
Led By Jason Burkholder, Ph.D.
Research Sponsored by Barron Associates, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Diagnosed with spastic CP
• No walking disabilities
Screening 3 weeks
Treatment Varies
Follow Up five minutes
Awards & highlights
No Placebo-Only Group

Study Summary

This trial is testing a computer-driven walker that will help people with walking disabilities by reducing the amount of energy needed to walk.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
You have been diagnosed with a type of cerebral palsy called spastic CP.
You are able to walk without any physical disabilities.
You have a moderate to severe level of mobility impairment.
It is not clear what "CP" refers to. Could you please provide more information or context?


Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~five minutes
This trial's timeline: 3 weeks for screening, Varies for treatment, and five minutes for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Metabolic Cost (oxygen consumption)

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: SurePace Powered Walker UserExperimental Treatment1 Intervention
Before any formal experiments are conducted, participants will be given an opportunity to "train" with the new powered walker for a pre-defined period of time to eliminate the confounding effects of being unfamiliar with using the device. (See the description of UVA's facilities and Protection of Human Subjects document for additional discussion of safety measures/protocols and Institutional Review Board procedures.) Experiments will consist of one-hour sessions (with adequate rest periods between trials and time for evaluations) in which participants will be asked to walk at a self-selected (comfortable) walking speed through a pre-defined 8 m x 4 m oval course.
First Studied
Drug Approval Stage
How many patients have taken this drug
SurePace Powered Walker User

Find a Location

Who is running the clinical trial?

National Institutes of Health (NIH)NIH
2,663 Previous Clinical Trials
6,694,555 Total Patients Enrolled
7 Trials studying Cerebral Palsy
1,025 Patients Enrolled for Cerebral Palsy
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)NIH
1,941 Previous Clinical Trials
2,659,910 Total Patients Enrolled
29 Trials studying Cerebral Palsy
8,715 Patients Enrolled for Cerebral Palsy
Barron Associates, Inc.Lead Sponsor
6 Previous Clinical Trials
186 Total Patients Enrolled

Media Library

Intelligent and Adaptive Control (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05465239 — N/A
Cerebral Palsy Research Study Groups: SurePace Powered Walker User
Cerebral Palsy Clinical Trial 2023: Intelligent and Adaptive Control Highlights & Side Effects. Trial Name: NCT05465239 — N/A
Intelligent and Adaptive Control (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05465239 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Can individuals of advanced age participate in this trial?

"To take part in this medical trial, patients must be aged 6 to 75. Additionally, there are 140 studies for minors and 26 for the elderly population."

Answered by AI

Are there any current opportunities for participation in this research project?

"Affirmative. Clinicaltrials.gov data reveals that this clinical trial, first published on September 1st 2020, is actively recruiting patients. The hunt for the necessary 60 participants will take place at a single location."

Answered by AI

How many participants are currently engaged in this trial?

"Affirmative, the information on clinicaltrials.gov suggests that this trial is actively recruiting participants. It was first published on September 1st 2020 and has since been updated for the final time on July 26th 2022. Sixty patients need to be enrolled from a single medical centre."

Answered by AI

Is it possible for me to participate in this medical experiment?

"This trial, which seeks to recruit sixty cerebral palsy patients aged between 6 and 75 years old, necessitates that participants meet a number of prerequisites; these include the ability to ambulate 40ft without aid (except for walking aids), GMFCS level II-III, an absence of surgeries in the past six months, proficiency in understanding and following commands, spastic CP diagnosis and being within the age range 5-25."

Answered by AI
~11 spots leftby Feb 2025